EPISODE · Sep 18, 2019 · 15 MIN
Breast CA Medical Risk Reduction: USPSTF Sept 2019 Guidelines
from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls
In Sept 2019, the USPTF revised and updated its 2013 recommendations on medications for risk reduction of primary breast cancer. Who qualifies for medical strategies? Which meds are recommended? In this session we will highlight the new USPSTF Guidelines, review the use of Prediction Models, and compare Tamoxifen, Raloxifene, and Aromatase Inhibitors.
Embed this episode
NOW PLAYING
Breast CA Medical Risk Reduction: USPSTF Sept 2019 Guidelines
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.